VAERS reports by lot

GSK Varicella/Shingles lot 49R72: VAERS reports

53 VAERS reports list lot 49R72 as a GSK Varicella/Shingles vaccine, received between 2018-11-02 and 2021-04-06. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
53
Reports
8%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5425%
Injection-site / Local reaction4721%
Neurological3315%
Dermatological (non-injection-site)2210%
Musculoskeletal2110%
Gastrointestinal146%
Allergic / Anaphylactic136%
Cardiac / Cardiovascular73%
Respiratory42%
Psychiatric / Neuropsychiatric42%
Autoimmune / Immune-mediated10%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas7
Louisiana7
California5
Oregon3
Missouri3
Wisconsin3
Tennessee2
Maryland2
Ohio2
Florida2
Kentucky2
Michigan2

Reports by month received

2018-1118
2018-1210
2019-017
2019-024
2019-034
2019-042
2019-062
2019-071
2019-092
2020-061
2020-101
2021-041

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.